SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Agent 3/30/15 Aurinia Pharmaceuticals Inc. 40-F 12/31/14 9:1.6M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size 1: 40-F Annual Report by a Canadian Issuer HTML 38K 2: EX-99.1 Miscellaneous Exhibit HTML 285K 3: EX-99.2 Miscellaneous Exhibit HTML 422K 4: EX-99.3 Miscellaneous Exhibit HTML 182K 5: EX-99.4 Miscellaneous Exhibit HTML 12K 6: EX-99.5 Miscellaneous Exhibit HTML 12K 7: EX-99.6 Miscellaneous Exhibit HTML 8K 8: EX-99.7 Miscellaneous Exhibit HTML 8K 9: EX-99.8 Miscellaneous Exhibit HTML 8K
EX-99.8 |
Exhibit 99.8
Consent of Independent Auditor
We hereby consent to the inclusion in this Annual Report on Form 40-F for the year ended December 31, 2014 of Aurinia Pharmaceuticals Inc. of our report dated March 26, 2015, relating to the consolidated financial statements, which appears in the Annual Report.
We also consent to reference to us under the heading “Interests of Experts,” which appears in the Annual Information Form incorporated by reference in this Annual Report on Form 40-F.
“PricewaterhouseCoopers LLP”
Chartered Accountants
Edmonton, Alberta
PricewaterhouseCoopers LLP
TD Tower, 10088 102 Avenue NW, Suite 1501, Edmonton, Alberta, Canada T5J 3N5
T: +1 780 441 6700, F: +1 780 441 6776, www.pwc.com/ca
“PwC” refers to PricewaterhouseCoopers LLP, an Ontario limited liability partnership.
This ‘40-F’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 3/30/15 | 6-K | ||
3/26/15 | ||||
For Period End: | 12/31/14 | 40-F/A | ||
List all Filings |